APPLICATION
ANDA214575
TYPE
ANDA
ORIGINAL APPROVAL
2021-06-25
LATEST ACTION
2024-09-30
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
DOCETAXELDiscontinued
DOCETAXEL 160MG/16ML (10MG/ML) · INJECTABLE · INJECTION
DOCETAXELDiscontinued
DOCETAXEL 20MG/2ML (10MG/ML) · INJECTABLE · INJECTION
DOCETAXELDiscontinued
DOCETAXEL 80MG/8ML (10MG/ML) · INJECTABLE · INJECTION
Approval history
2024-09-30Labeling · Supplement 2 · standardAP
2021-06-25UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.